Capacity Bio is developing the most comprehensive and advanced mitophagy therapeutics and development platform for the purpose of restoring mitochondria quality control in disease.

Market:

Our lead focus is neurodegeneration and muscular disorders, including Parkinson’s, ALS, and DMD which targets multibillion opportunities.
 

Technology:

Capacity Bio has a unique set of drugs that improve mitochondrial quality control by targeting receptors on the cell surface.

Advantages:

  • Engage target quickly and efficiently
  • No need to enter the cell or mitochondria
  • Safe and effective

    Development Stage:

    • Pre-clinical

    Patents Pending:

    • Coming Soon

      Contact:

      Website: www.capacitybio.com Phone: (310) 880-6414 Email: awang@capacitybio.com LinkedIn